Research—basic, clinical, and translational—has become a central element of the work of the Methodist Neurological Institute. While we are still in the earliest phases of the development of our research programs, our clinicians and researchers have made significant contributions to advances in key therapeutic areas, including stroke, ALS, Alzheimer’s disease, epilepsy, migraine and Parkinson’s disease.
Clinical trials are voluntary research studies, conducted in people, that are designed to answer specific questions about the safety and/or effectiveness of drugs, vaccines, other therapies, or new ways of using existing treatments. More information to help you understand clinical trials, at ClinicalTrials.gov
Faculty in the Department of Neurology, at Methodist Neurological Institute have conducted phase I, II clinical trials in various subspecialties in neurology. In the past 25 years we have been involved in over 30 protocols in the following therapeutic areas: